Garware Fulflex acquires Texas facility
Analysis based on 7 articles · First reported Jul 06, 2026 · Last updated Jul 17, 2026
The acquisition strengthens Garware Fulflex's position in the global medical products market and is expected to double its revenue. It enhances supply chain resilience and proximity to the North American healthcare market, potentially improving customer relationships and operational efficiency.
Garware Fulflex, an Indian healthcare manufacturing company, completed the acquisition of a 300,000-square-foot fully automated medical products manufacturing facility in United States — Jacksonville, Texas. The facility employs over 250 people and produces critical medical products using advanced injection molding, blow molding, thermoforming, extrusion, assembly, and quality systems. The acquisition is expected to double Garware Fulflex's global revenue from approximately $100 million to $200 million, significantly expanding its scale and manufacturing footprint in North America. Chairperson Diya Garware Ibanez called the acquisition a defining milestone in building a globally respected healthcare manufacturing company. The company now operates 14 locations worldwide, including four in the US, one in the Dominican Republic, two in India, and seven sales offices and distribution centers, serving customers in over 85 countries.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard